Champions Oncology
CSBR
28 hedge funds and large institutions have $36.3M invested in Champions Oncology in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
12% more funds holding
Funds holding: 25 → 28 (+3)
10% more capital invested
Capital invested by funds: $33M → $36.3M (+$3.32M)
1.13% more ownership
Funds ownership: 41.28% → 42.41% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.16M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$110K |
| 3 |
Mercer Global Advisors
Denver,
Colorado
|
+$77K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$40.6K |
| 5 |
BlackRock
New York
|
+$35.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
-$145K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$138K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$109K |
| 4 |
Morgan Stanley
New York
|
-$41.6K |
| 5 |
Renaissance Technologies
New York
|
-$39.2K |
CSBR Hedge Fund Activity: Q2 2026 in Review
28 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2026, worth a combined $36.3M — up 10% from $33M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CSBR positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Bank of America, adding an estimated $1.16M. The largest seller was Tocqueville Asset Management, cutting an estimated $145K.
- 28 institutional investors held Champions Oncology (CSBR) as of Q2 2026, up from 25 in Q1 2026.
- Funds reported $36.3M of Champions Oncology stock for Q2 2026, up 10% quarter-over-quarter.
- 4 funds opened new Champions Oncology positions in Q2 2026 and 1 closed out, a net change of +3 holders.
- The largest Champions Oncology buyer in Q2 2026 was Bank of America, an estimated $1.16M added.
- The largest Champions Oncology seller in Q2 2026 was Tocqueville Asset Management, an estimated $145K sold.
Based on aggregated 13F filings for Q2 2026.